Additional challenges need to be addressed, such as lack of FAIR data, access to necessary resources and skills and internal change management.
TORONTO (PRWEB)
September 07, 2022
The emergence of knowledge graphs, artificial intelligence (AI), machine learning and FAIR (Findable, Accessible, Interoperable and Reusable) data principles has created a unique opportunity within the biopharmaceutical industry to capitalize on the explosion of growth in data in the last 10 years. However, there remain significant barriers to adoption of these approaches, specifically in the biotech sector where there is a need to maximize cost effectiveness in choosing tools that get results fast and allow them to scale. There is a strong desire to investigate and leverage data science, AI and machine learning approaches in drug discovery and democratize insights across the organization. However, additional challenges need to be addressed, such as lack of FAIR data, access to necessary resources and skills and internal change management.
Attendees will gain insights into a unique knowledge management platform that harmonizes siloed, disparate data using a powerful data ingestion engine and underlying knowledge graph. The platform’s flexible user interface is customized to shield end-users from complexity which enables Aelin Therapeutics and e-therapeutics to democratize insights across their wider organization to support rapid, crucial research & development decision making to accelerate their drug discovery process.
In this webinar, attendees will hear from the CIO of Aelin Therapeutics, a biotech company that leverages targeted protein aggregation to develop a completely new class of therapeutics, aiming at hard-to-treat targets in cancer and infectious diseases, and the Head of Discovery Biology at e-therapeutics, a biotech company that integrates computational power and biology to discover life-transforming RNAi medicines. The featured speakers will discuss how they collaborate with ONTOFORCE, a Life Sciences technology company which transforms data into knowledge by unlocking hidden insights from data.
Register to learn how the adoption and usage of knowledge graphs, AI and machine learning approaches accelerates drug discovery.
Join James Longden, Head of Discovery Biology, e-therapeutics; and Paul Vauterin, CIO, Aelin Therapeutics, for the live webinar on Tuesday, September 27, 2022, at 9am EDT (3pm CEST/EU-Central).
For more information, or to register for this event, visit How Knowledge Graphs Accelerate Drug Discovery in Biotechs.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/
Share article on social media or email: